Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

Disni Muringampurath-John, Christopher R. Flowers, Michael Toscano, Chen Zhengjia, Jonathan L. Kaufman, Martha Arellano, Leon Bernal-Mizrachi, Leonard T. Heffner, Mary Jo Lechowicz, Morgan McLemore, Elliott Winton, David L. Jaye, Sagar Lonial, Hanna Jean Khoury

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma'. Together they form a unique fingerprint.